German Trial Finds No Significant Hospitalization Drop From Multifaceted Nursing Home Telemedicine
A rigorous German cluster trial demonstrated that an ambitious telemedicine package did not produce statistically detectable reductions in nursing-home hospitalizations. Implementation barriers, workforce strain, and concurrent crises outweighed the intervention's theoretical advantages. Future programs should target narrow, avoidable admissions and incorporate automated monitoring with stronger primary-care integration.
The Optimal@NRW intervention combined continuous remote physician access, nonphysician mobile teams, and an early-warning software platform. Researchers collected primary facility data and statutory health insurance claims from May 2021 through April 2023, then applied specification-curve analysis to test robustness across mixed-effects regressions. No specification reached the prespecified P < .05 threshold. External shocks including 2021 floods and COVID restrictions altered baseline admission rates, while daily manual vital-sign entry increased staff burden in facilities already short on personnel. General-practitioner participation remained low, limiting intersectoral coordination. The trial therefore illustrates that complex digital bundles can fail when operational friction and external volatility exceed the intervention's capacity to alter admission thresholds.
Grosser et al.: Within 36 months, at least one European RCT of wearable-automated vital-sign monitoring in nursing homes will report a >15% relative reduction in avoidable hospitalizations with P < .05.
Sources (3)
- [1]Primary Source(https://doi.org/10.2196/75721)
- [2]Supporting Source(https://jamanetwork.com/journals/jama/fullarticle/2787993)
- [3]Supporting Source(https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(22)00045-7/fulltext)